U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT07532239) titled 'Survey of Knowledge, Practice, and Recommendation Behaviors Regarding Healthy Lifestyles A... Read More
U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT07530848) titled 'Perioperative Pharmacokinetics of Anesthetic Drugs and Complications in Overweight and Obe... Read More
U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT07530666) titled 'Study of the Safety and Efficacy of DS010 in Patients With Cancer Cachexia' on April 01. ... Read More
U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT07531264) titled 'EMG-guided Neuro-Intermuscular Coordination Enhancement (NICE) Rehabilitation Through Huma... Read More
Singapore, April 16 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More
Singapore, April 16 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More
Singapore, April 16 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More
Singapore, April 16 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More
Singapore, April 16 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More
Singapore, April 16 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) ... Read More